Sarepta Therapeutics (SRPT) Non Operating Income (2010 - 2026)

Sarepta Therapeutics' Non Operating Income history runs 17 years deep, the most recent figure standing at -$15.3 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 81.64% year-over-year to -$15.3 million; the TTM figure through Mar 2026 stood at $48.6 million (up 203.37% YoY), while the FY2025 annual figure was -$19.3 million, down 145.22% from the prior year.
• Non Operating Income was -$15.3 million for Q1 2026 at Sarepta Therapeutics, down from $116.4 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $116.4 million in Q4 2025 to a low of -$90.7 million in Q3 2025.
• Historically, Non Operating Income has averaged $756588.2 across 5 years, with a median of $6.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Non Operating Income plunged 27076.56% in 2022, then soared 1057.08% in 2025.
• A 5-year view of Non Operating Income shows it stood at $5.5 million in 2022, then jumped by 184.89% to $15.7 million in 2023, then sank by 36.1% to $10.1 million in 2024, then jumped by 1057.08% to $116.4 million in 2025, then tumbled by 113.11% to -$15.3 million in 2026.
• The last three Non Operating Income figures came in at -$15.3 million (Q1 2026), $116.4 million (Q4 2025), and -$90.7 million (Q3 2025), per Business Quant data.